Synthesis and biological evaluation of resveratrol derivatives with anti-breast cancer activity.


Journal

Archiv der Pharmazie
ISSN: 1521-4184
Titre abrégé: Arch Pharm (Weinheim)
Pays: Germany
ID NLM: 0330167

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 17 02 2020
revised: 01 04 2020
accepted: 02 04 2020
pubmed: 29 4 2020
medline: 2 2 2021
entrez: 29 4 2020
Statut: ppublish

Résumé

Resveratrol is a natural phytoestrogen produced by plants to protect themselves from injury, UV irradiation, and fungal attack. The main active structure is E-resveratrol, which has many pharmacological activities. As the structure of resveratrol is similar to the natural estrogen 17β-estradiol and the synthetic estrogen E-diethylstilbestrol, resveratrol is used in reducing the incidence of breast cancer. However, the therapeutic application of resveratrol is limited due to its low bioavailability. To improve its bioavailability and pharmacological activity, some resveratrol derivatives have been designed and synthesized by substitutions of methoxy, hydroxyl, and other functional groups or heterocyclic esterification either on the "A" or "B" ring, and double bonds were replaced by imine bonds and isometric heterocycles such as naphthyl and imidazole, or synthetic resveratrol oligomers. The structures, synthetic routes, and evaluation of the biological activities of these compounds are discussed. These are aimed at providing some references for the study of resveratrol derivatives in anti-breast cancer treatment.

Identifiants

pubmed: 32342549
doi: 10.1002/ardp.202000044
doi:

Substances chimiques

Antineoplastic Agents 0
Resveratrol Q369O8926L

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2000044

Informations de copyright

© 2020 Deutsche Pharmazeutische Gesellschaft.

Références

M. Q. Li, Y. H. Lao, R. L. Mintz, Z. G. Chen, D. Shao, H. Z. Hu, H. X. Wang, Y. Tao, K. W. Leong, Nanoscale 2019, 11, 2631.
S. Aghamiri, A. Jafarpour, F. Zandsalimi, M. Aghemiri, M. Shoja, J. Cell. Biochem. 2019, 120, 15671.
R. L. Siegel, K. D. Miller, A. Jemal, CA Cancer J. Clin. 2019, 69, 7.
M. Jia, D. W. Karin, J. Å. Gustafsson, Best Pract Res. Clin. Endocrinol. Metab. 2015, 29, 557.
X. P. Shi, S. Miao, Y. Wu, W. Zhang, X. F. Zhang, H. Z. Ma, H. L. Xin, J. Feng, A. D. Wen, Y. Li, Int. J. Mol. Sci. 2013, 14, 15655.
K. Zhu, L. J. Bernard, R. S. Levine, S. M. Williams, Med. Hypotheses 1997, 49, 69.
N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, J. A. Gustafsson, Physiol. Rev. 2007, 87, 905.
A. Shrivastav, M. Bruce, D. Jaksic, T. Bader, S. Seekallu, C. Penner, Z. Nugent, P. Watson, L. Murphy, Breast Cancer Res. 2014, 16, R49.
W. K. Dahlman, V. Cavailles, S. A. Fuqua, V. C. Jordan, J. A. Katzenellenbogen, K. S. Korach, A. Maggi, M. Muramatsu, M. G. Parker, J. A. Gustafsson, Pharmacol. Rev. 2006, 58, 773.
C. Hu, Y. Liu, M. Teng, K. Jiao, J. Zhen, M. Wu, Z. Li, Cell Biol. Toxicol. 2019, 35, 445.
N. Chowdhury, I. Vhora, K. Patel, A. Bagde, S. Kutlehria, M. Singh, AAPS Pharm. Sci. Tech. 2018, 19, 3287.
M. S. Donaldson, Nutr. J. 2004, 3, 19.
Y. Q. Xue, J. M. Di, Y. Luo, K. J. Cheng, X. Wei, Z. Shi, Oxid. Med. Cell Longevity 2014, 2014, 765832.
L. Biasutto, A. Mattarei, M. Azzolini, M. La Spina, N. Sassi, M. Romio, C. Paradisi, M. Zoratti, Ann. N. Y. Acad. Sci. 2017, 1403, 27.
L. Kuršvietienė, I. Stanevičienė, A. Mongirdienė, J. Bernatonienė, Medicina 2016, 52, 148.
C.-F. Wu, J.-Y. Yang, F. Wang, X.-X. Wang, Chin. J. Nat. Med. 2013, 11, 1.
W. Nawaz, Z. Zhou, S. Deng, X. Ma, X. Ma, C. Li, X. Shu, Nutrients 2017, 9, 1188.
Y. Hu, S. Wang, X. Wu, J. Zhang, R. Chen, M. Chen, Y. Wang, J. Ethnopharmacol. 2013, 149, 601.
J. Belleville, Nutrition 2002, 18, 173.
L. Mrkus, J. Batinic, N. Bjelis, A. Jakas, Amino Acids 2019, 51, 319.
W. Y. Oh, F. Shahidi, Food Chem. 2018, 261, 267.
M. Vestergaard, H. Ingmer, Int. J. Antimicrob. Agents 2019, 53, 716.
Y. W. Tang, C. J. Shi, H. L. Yang, P. Cai, Q. H. Liu, X. L. Yang, L. Y. Kong, X. B. Wang, Eur. J. Med. Chem. 2019, 163, 307.
S. You, J. Qian, C. Sun, H. Zhang, S. Ye, T. Chen, Z. Xu, J. Wang, W. Huang, G. Liang, J. Cell Mol. Med. 2018, 22, 1931.
H. J. Yang, Y. J. Ren, C. Du, L. Jin, R. Li, N. Xie, Chem. Nat. Compd. 2018, 54, 864.
N. Singh, M. Agrawal, S. Doré, ACS Chem. Neurosci. 2013, 4, 1151.
F. De Amicis, F. Giordano, A. Vivacqua, M. Pellegrino, M. L. Panno, D. Tramontano, S. A. Fuqua, S. Ando, FASEB J. 2011, 25, 3695.
G. T. Diaz-Gerevini, G. Repossi, A. Dain, M. C. Tarres, U. N. Das, A. R. Eynard, Nutrition 2016, 32, 174.
C. Du, M. H. Dong, Y. J. Ren, L. Jin, C. Xu, J. Asian Nat. Prod. Res. 2017, 19, 890.
R. Lappano, C. Rosano, A. Madeo, L. Albanito, P. Plastina, B. Gabriele, L. Forti, L. A. Stivala, D. Iacopetta, V. Dolce, S. Ando, V. Pezzi, M. Maggiolini, Mol. Nutr. Food Res. 2010, 53, 845.
A. Siddiqui, P. Dandawate, R. Rub, S. Padhye, S. Aphale, A. Moghe, A. Jagyasi, K. Venkateswara Swamy, B. Singh, A. Chatterjee, A. Ronghe, H. K. Bhat, Bioorg. Med. Chem. Lett. 2013, 23, 635.
W. Zhang, M. L. Go, Eur. J. Med. Chem. 2007, 42, 841.
F. Alonso, P. Riente, M. Yus, Tetrahedron Lett. 2009, 50, 3070.
S. Eddarir, A. Zouanate, R. Christian, Tetrahedron Lett. 2001, 42, 9127.
L.-O. Francisco, S.-M. Leticia C, E.-P. Georgina, Tetrahedron Lett. 2015, 56, 5977.
F. P. Chen, M. H. Chien, Climacteric 2014, 17, 682.
B. Wicklow, K. Wittmeier, G. W. T'Jong, J. Mcgavock, M. Robert, T. Duhamel, V. W. Dolinsky, Biochem. Cell Biol. 2015, 93, 522.
H. Wu, L. Chen, F. Zhu, X. Han, L. Sun, K. Chen, Toxins 2019, 11.
M. Athar, J. H. Back, L. Kopelovich, D. R. Bickers, A. L. Kim, Arch. Biochem. Biophys. 2009, 486, 95.
A. Bhardwaj, G. Sethi, S. Vadhan-Raj, C. Bueso-Ramos, Y. Takada, U. Gaur, A. S. Nair, S. Shishodia, B. B. Aggarwal, Blood 2007, 109, 2293.
K. B. Harikumar, B. B. Aggarwal, Cell Cycle 2008, 7, 1020.
Y. C. Duan, Y. Y. Guan, X. Y. Zhai, L. N. Ding, W. P. Qin, D. D. Shen, X. Q. Liu, X. D. Sun, Y. C. Zheng, H. M. Liu, Eur. J. Med. Chem. 2017, 126, 246.
S. J. Baek, N. C. Whitlock, Evidence-based Anticancer Materia Medica, Springer, Dordrecht, 2011, https://doi.org/10.1007/978-94-007-0526-5_15
M. S. Jang, E. N. Cai, G. O. Udeani, K. V. Slowing, C. F. Thomas, C. W. Beecher, H. S. Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, R. C. Moon, J. M. Pezzuto, Science 1997, 275, 218.
A. Alayev, P. F. Doubleday, S. M. Berger, B. A. Ballif, M. K. Holz, J. Proteome Res. 2014, 13, 5734.
H. Vundavilli, A. Datta, C. Sima, J. P. Hua, R. Lopes, M. Bittner, IEEE Trans. Biomed. Eng. 2019, 66, 2684.
J. Gambini, M. Ingles, G. Olaso, R. Lopez-Grueso, V. Bonet-Costa, L. Gimeno-Mallench, C. Mas-Bargues, K. M. Abdelaziz, M. C. Gomez-Cabrera, J. Vina, C. Borras, Oxid. Med. Cell Longevity 2015, 2015, 837042.
Y. Xiao, H. F. Chen, C. Song, X. L. Zeng, Q. T. Zheng, Y. X. Zhang, X. Y. Lei, X. Zheng, Pharmazie 2015, 70, 765.
N. Pannu, A. Bhatnagar, Biomed. Pharmacother. 2019, 109, 2237.
T. Walle, Ann. N. Y. Acad. Sci. 2011, 1215, 9.
J. M. Estrela, A. Ortega, S. Mena, M. L. Rodriguez, M. Asensi, Crit. Rev. Clin. Lab Sci. 2013, 50, 65.
F. Minutolo, G. Sala, A. Bagnacani, S. Bertini, I. Carboni, G. Placanica, G. Prota, S. Rapposelli, N. Sacchi, M. Macchia, J. Med. Chem. 2005, 48, 6783.
H. Y. Tsai, C. T. Ho, Y. K. Chen, J. Food Drug Anal. 2017, 25, 134.
J. K. Takemoto, C. M. Remsberg, N. M. Davies, J. Pharm. Pharm. Sci. 2015, 18, 713.
J.-H. Tsai, L.-S. Hsu, C.-L. Lin, H.-M. Hong, M.-H. Pan, T.-D. Way, W.-J. Chen, Toxicol. Appl. Pharmacol. 2013, 272, 746.
G. Traversi, M. Fiore, Z. Percario, F. Degrassi, R. Cozzi, Mol. Carcinog. 2017, 56, 1117.
Y. Wang, L. Ding, X. Wang, J. Zhang, X. J. Wang, Am. J. Transl. Res. 2012, 4, 44.
R. Kala, H. N. Shah, S. L. Martin, T. O. Tollefsbol, BMC Cancer 2015, 15, 672.
J. S. Castresana, R. Kala, T. O. Tollefsbol, PLOS One 2016, 11, e0155057.
G. Laudadio, G. Fusini, G. Casotti, C. Evangelisti, G. Angelici, A. Carpita, J. Flow Chem. 2019, 9, 133.
M. H. Pan, C. L. Lin, J. H. Tsai, C. T. Ho, W. J. Chen, J. Agric. Food Chem. 2010, 58, 226.
A. Chimento, F. De Amicis, R. Sirianni, M. S. Sinicropi, F. Puoci, I. Casaburi, C. Saturnino, V. Pezzi, Int. J. Mol. Sci. 2019, 20, 1381.
H. S. Lin, C. Spatafora, C. Tringali, P. C. Ho, J. Pharm. Biomed. Anal. 2012, 57, 94.
B. Licznerska, H. Szaefer, M. Wierzchowski, H. Sobierajska, W. Baer-Dubowska, Mol. Cell. Biochem. 2017, 425, 169.
C. Maccario, M. Savio, D. Ferraro, L. Bianchi, R. Pizzala, L. Pretali, L. Forti, L. A. Stivala, Carcinogenesis 2012, 33, 2172.
H. Piotrowska, M. Kucinska, M. Murias, Mutat. Res. 2012, 750, 60.
H. S. Ko, H. J. Lee, S. H. Kim, E. O. Lee, J. Agric. Food Chem. 2012, 60, 4083.
N. R. Song, M. K. Hwang, Y. S. Heo, K. W. Lee, H. J. Lee, Int. J. Mol. Med. 2013, 32, 775.
J. Mikuła-Pietrasik, P. Sosińska, M. Wierzchowski, K. Piwocka, K. Książek, Int. J. Mol. Sci. 2013, 14, 22483.
M. Murias, M. W. Luczak, A. Niepsuj, V. Krajka-Kuzniak, M. Zielinska-Przyjemska, P. P. Jagodzinski, W. Jager, T. Szekeres, J. Jodynis-Liebert, Toxicol. In Vitro 2008, 22, 1361.
Y. Kong, J. Grembecka, M. C. Edler, E. Hamel, S. L. Mooberry, M. Sabat, J. Rieger, M. L. Brown, Chem. Biol. 2005, 12, 1007.
Y. Kong, K. Wang, M. C. Edler, E. Hamel, S. L. Mooberry, M. A. Paige, M. L. Brown, Bioorg. Med. Chem. 2010, 18, 971.
M. Zoldakova, B. Biersack, H. Kostrhunova, A. Ahmad, S. Padhye, F. Sarkar, R. Schobert, V. Brabec, Med. Chem. Commun. 2011, 2, 493.
V. M. Yenugonda, Y. Kong, T. B. Deb, Y. Yang, R. B. Riggins, M. L. Brown, Cancer Biol. Ther. 2012, 13, 925.
F. Bellina, N. Guazzelli, M. Lessi, C. Manzini, Tetrahedron 2015, 71, 2298.
J. L. Espinoza, P. T. Inaoka, Ann. N. Y. Acad. Sci. 2017, 1403, 5.
Y. Gao, C. He, R. Ran, D. Zhang, D. Li, P. G. Xiao, E. Altman, J. Ethnopharmacol. 2015, 169, 24.
B. S. Matsuura, M. H. Keylor, B. Li, Y. X. Lin, S. Allison, D. A. Pratt, C. R. J. Stephenson, Angew. Chem. Int. Ed. Engl. 2015, 54, 3754.

Auteurs

Mei-Fang Yang (MF)

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Xu Yao (X)

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Li-Mei Chen (LM)

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Jin-Ying Gu (JY)

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Ze-Hua Yang (ZH)

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Hong-Fei Chen (HF)

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Xing Zheng (X)

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Zi-Tong Zheng (ZT)

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH